These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8052994)
61. An alternative hypothesis for bladder cancer among workers exposed to ortho-toluidine and aniline. Acquavella JF; Wilson JD; Conner P; Bannister R J Natl Cancer Inst; 1991 Nov; 83(22):1686-7. PubMed ID: 1749022 [No Abstract] [Full Text] [Related]
62. Environmental and biological control. Scott TS Proc R Soc Med; 1966 Dec; 59(12):1248-51. PubMed ID: 5955213 [No Abstract] [Full Text] [Related]
63. Specific aromatic amines as occupational bladder carcinogens. Clayson DB Natl Cancer Inst Monogr; 1981 Dec; (58):15-9. PubMed ID: 7341971 [TBL] [Abstract][Full Text] [Related]
65. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess. Stephens ER J Natl Cancer Inst; 1997 May; 89(10):734-5; author reply 735-6. PubMed ID: 9168192 [No Abstract] [Full Text] [Related]
66. Dyestuffs and bladder cancer. Howard K N Z Med J; 1993 Sep; 106(963):391. PubMed ID: 8367102 [No Abstract] [Full Text] [Related]
68. Bladder cancer in workers exposed to aniline. Tannenbaum SR J Natl Cancer Inst; 1991 Oct; 83(20):1507-8. PubMed ID: 1920498 [No Abstract] [Full Text] [Related]
69. Bladder cancer amongst dye users. Cartwright RA; Bernard SM; Glashan RW; Gray BK Lancet; 1979 Nov; 2(8151):1073-4. PubMed ID: 91807 [No Abstract] [Full Text] [Related]
70. Changes in compensation for occupationally induced bladder cancer. Glashan RW Br Med J (Clin Res Ed); 1984 Apr; 288(6425):1181-2. PubMed ID: 6231971 [No Abstract] [Full Text] [Related]
71. [Skin exposure to carbon black and bladder tumors]. Traversa F; Giacchero F; Giacinti F; Vitto V G Ital Med Lav Ergon; 2003; 25 Suppl(3):75-6. PubMed ID: 14979091 [TBL] [Abstract][Full Text] [Related]
72. Tryptophan metabolism in patients with bladder cancer of occupational etiology. Brown RR; Friedell GH; Leklem JE Am Ind Hyg Assoc J; 1972 Apr; 33(4):217-22. PubMed ID: 5080673 [No Abstract] [Full Text] [Related]
73. Systematic investigation needed for tight building syndrome complaints. Morgan MS; Horstman SW Occup Health Saf; 1987 May; 56(5):79-82, 85-8. PubMed ID: 3587816 [No Abstract] [Full Text] [Related]
74. Overrepresentation of the slow acetylator phenotype in painters suffering from urinary bladder cancer. Golka K; Kempkes M; Flieger A; Blaszkewicz M; Bolt HM Med Lav; 1997; 88(5):425-6. PubMed ID: 9489306 [No Abstract] [Full Text] [Related]
75. Recent approaches to the control of carcinogenic exposures. Case study 2: Benzidine and 2-naphthylamine - voluntary substitution or technological alternatives. Clayson DB Ann N Y Acad Sci; 1976; 271():170-5. PubMed ID: 1069499 [No Abstract] [Full Text] [Related]
76. The identification and control of occupational bladder cancer. Parkes HG IARC Sci Publ (1971); 1979; (25):47-58. PubMed ID: 378817 [TBL] [Abstract][Full Text] [Related]
77. [Nine cases of bladder cancer occurring in occupational dye users]. Murase T; Takashi M; Aota Y; Shimoji T; Miyake K; Mitsuya H Hinyokika Kiyo; 1985 Aug; 31(8):1459-62. PubMed ID: 4083208 [TBL] [Abstract][Full Text] [Related]
78. [Causes of bladder carcinoma]. Fokkens W Ned Tijdschr Geneeskd; 1973 Jul; 117(29):1088-94. PubMed ID: 4593760 [No Abstract] [Full Text] [Related]
79. Associations between cancer and employment. Davis LK; Martin TR Am J Public Health; 1988 May; 78(5):594. PubMed ID: 3354750 [No Abstract] [Full Text] [Related]